Sequist: Uses cobas EGFR PCR ctDNA test; FAST-ACT2 trial, chemo w/erlotinib or placebo. '15 ref https://t.co/Ncse6ODg4Q #FDA-AACR

10:44am July 19th 2016 via Hootsuite